What Is Vitiligo? White Skin Patches, Causes & Treatment Options

What Is Vitiligo? White Skin Patches, Causes & Treatment Options

What Is Vitiligo? White Skin Patches, Causes & Treatment Options

Vitiligo is a chronic autoimmune disorder in which melanocytes are damaged or destroyed, causing sharply lighter or completely depigmented white patches on the skin. It is a true depigmentation disorder rather than a generic form of hypopigmentation, and it is not contagious.

Recognizing vitiligo means understanding the difference between segmental and nonsegmental patterns, knowing how Wood’s lamp examination helps confirm true pigment loss and separating vitiligo from common white-patch mimics. Management then focuses on stabilizing active disease, encouraging repigmentation where desired, protecting depigmented skin from sunburn and monitoring for recurrence or associated autoimmune features.

Medical note: This article is for educational purposes only. New rapidly spreading white patches, uncertain diagnosis, significant autoimmune symptoms or major quality-of-life impact should be discussed with a qualified healthcare professional.

What Is Vitiligo and What Do Its White Skin Patches Look Like?

Vitiligo is an autoimmune pigment disorder in which melanocyte loss produces flat, sharply lighter or completely white depigmented skin patches with otherwise normal surface texture.

What Happens to Melanocytes in Vitiligo?

Immune dysregulation causes melanocytes to be targeted and damaged, reducing or eliminating melanin production in affected skin. The core mechanism is autoimmune attack on melanocytes, which leads to loss of epidermal pigment and visible depigmented patches.

Why Does Melanocyte Loss Make the Skin White?

Melanocytes normally produce melanin, so losing these pigment-producing cells leaves affected epidermis with little or no melanin and creates a true white patch. This is why vitiligo is best described as depigmentation rather than simply “lighter skin.”

Is Vitiligo Contagious?

No; vitiligo is an autoimmune pigment disorder and cannot be caught through touching, sharing items or close contact. It is not fungal, not bacterial and not caused by poor hygiene.

What Do Typical Vitiligo Patches Look Like?

Typical vitiligo patches are flat, milky-white or fully depigmented areas with normal surface texture and usually a clear contrast from surrounding skin. Common sites include the face, hands, fingertips, feet, elbows, knees, around the eyes or mouth, genital skin and trauma-prone areas.

Can Vitiligo Turn Hair White?

Yes; hair growing within affected skin can lose pigment, producing leukotrichia or poliosis. This may affect scalp hair, eyebrows, eyelashes, beard hair or body hair and can influence repigmentation potential.

What Is Nonsegmental Vitiligo?

Nonsegmental vitiligo is the more common form and typically produces bilateral or relatively symmetrical patches that may progress, stabilize and later reactivate. Acrofacial and mucosal patterns fit within the broader nonsegmental spectrum.

What Is Segmental Vitiligo?

Segmental vitiligo usually affects one side or localized segment of the body and often progresses for a limited period before becoming stable. It commonly begins at a younger age than nonsegmental disease and is an important prognostic subtype.

What Is the Koebner Phenomenon?

The Koebner phenomenon occurs when new vitiligo patches appear at sites of friction, scratches or other skin injury in susceptible active disease. It is an activity clue, not proof that injury causes every case.

Vitiligo pattern map Illustrated map showing the major recognizable vitiligo patterns: nonsegmental, segmental, acrofacial, mucosal and leukotrichia. Vitiligo Pattern Map Recognize distribution, symmetry and hair involvement — not just “white skin.” NONSEGMENTAL bilateral / relatively symmetrical may progress, stabilize and recur SEGMENTAL unilateral / localized distribution often stabilizes after a limited phase ACROFACIAL face + hands / feet / fingertips common recognizable distribution MUCOSAL lip, genital or other mucosal involvement can occur alone or with wider disease LEUKOTRICHIA / POLIOSIS white hair within or near vitiligo patches suggests follicular pigment loss Pattern logic: bilateral vs unilateral • site distribution • mucosal involvement • hair whitening skinkeeps.com
Figure 1. Vitiligo is recognized by true depigmentation plus subtype pattern. Nonsegmental disease is usually bilateral or relatively symmetrical, while segmental disease is usually unilateral and more localized.

What Causes Vitiligo and Which Conditions Are Associated With It?

Vitiligo is primarily an autoimmune melanocyte-loss disorder influenced by genetic susceptibility, while skin trauma and selected autoimmune diseases can modify risk, distribution or clinical context.

Is Vitiligo an Autoimmune Disease?

Yes; the best-supported central mechanism is an immune response that mistakenly targets melanocytes. This autoimmune model explains why pigment disappears even though the skin surface often remains smooth and otherwise normal.

Does Genetics Contribute to Vitiligo?

Yes; genetics contribute to susceptibility, but vitiligo does not follow a simple single-gene inheritance pattern. Family history can increase risk, yet many affected people have no known family history.

Which Autoimmune Conditions Are Associated With Vitiligo?

Vitiligo can coexist with other autoimmune disorders, with autoimmune thyroid disease among the most important recognized associations. Other reported associations include type 1 diabetes, pernicious anemia, rheumatoid arthritis, Addison disease, lupus and alopecia areata, but most people with vitiligo do not develop all of these conditions.

How Is Lupus Related to the Autoimmune Context of Vitiligo?

Lupus Erythematosus is one of several autoimmune disorders reported in association with vitiligo, but it is a separate systemic autoimmune disease with its own diagnostic and treatment pathway.

Can Skin Injury Trigger New Vitiligo Patches?

Yes; friction or injury can trigger new lesions at trauma sites in susceptible people through the Koebner phenomenon. Injury can influence where lesions appear without being the root cause of the autoimmune disorder itself.

Can Sunburn Make Vitiligo More Noticeable or Worse?

Yes; depigmented skin burns more easily, and tanning of surrounding skin can increase contrast, while excessive UV injury may aggravate active disease. Controlled dermatologist-supervised phototherapy is therefore very different from ordinary sun exposure or tanning.

Can Diet or Vitamin Deficiency Be Blamed for Vitiligo?

No specific diet or vitamin deficiency has been established as the universal cause of vitiligo, and supplements should not be presented as reliable repigmentation therapy. Evidence is not strong enough to promise improvement from restrictive diets, herbal products or over-the-counter vitamin regimens.

Vitiligo cause and association model Illustrated model showing autoimmune targeting of melanocytes as the core mechanism of vitiligo, modified by genetic susceptibility, trauma or Koebner phenomenon, sunburn vulnerability, and selected autoimmune associations. Vitiligo Cause & Association Model Keep the hierarchy clear: core cause ≠ modifier ≠ association ≠ myth. AUTOIMMUNE TARGETING immune dysregulation damages melanocytes → loss of melanin → depigmented patches GENETIC SUSCEPTIBILITY contributes to risk but not simple inheritance TRAUMA / KOEBNER friction or injury may localize new lesions AUTOIMMUNE LINKS thyroid disease is key others can coexist SUNBURN VULNERABILITY less melanin protection more burn and contrast Myth boundary: vitiligo is not fungal, not hygiene-related, not contagious, and not a universal vitamin-deficiency disease. Action boundary: confirm depigmentation, assess autoimmune context selectively, protect skin from sunburn. skinkeeps.com
Figure 2. The core vitiligo mechanism is autoimmune melanocyte loss. Genetics can influence susceptibility, trauma can localize new lesions through the Koebner phenomenon, and selected autoimmune diseases provide associated clinical context.

How Is Vitiligo Diagnosed and Distinguished From Other White Skin Patches?

Vitiligo is usually diagnosed from the appearance and distribution of true depigmented patches, with Wood’s lamp examination helping confirm pigment loss and mimics considered when patches are scaly, partially pigmented or linked to prior inflammation.

How Does a Dermatologist Diagnose Vitiligo?

Diagnosis usually begins with the patch appearance, distribution, progression history and personal or family autoimmune context. Vitiligo is often a clinical diagnosis, especially when depigmented patches are sharply defined and occur in a typical pattern.

How Does a Wood’s Lamp Help?

A Wood’s lamp makes vitiligo depigmentation appear sharply bright or white by highlighting the absence of normal epidermal melanin. It is especially useful for subtle lesions, lighter skin tones or defining patch margins, but it still has to be interpreted in clinical context.

Are Blood Tests Needed for Everyone?

No; blood tests are selected according to symptoms, family history and clinical suspicion for associated autoimmune disease. Thyroid testing is a common consideration, but blanket autoimmune panels are not required for every person with vitiligo.

How Is Vitiligo Different From General Hypopigmentation?

Hypopigmentation describes reduced pigment from many possible causes, while vitiligo usually causes true depigmentation from melanocyte loss. That difference matters because a light patch is not automatically vitiligo.

How Is Vitiligo Different From Pityriasis Alba?

Pityriasis Alba usually produces lighter rather than completely depigmented patches and may have subtle scale, especially on the face. Vitiligo, by contrast, tends to be smoother, more sharply depigmented and not characteristically scaly.

How Is Vitiligo Different From Tinea Versicolor?

Vitiligo is autoimmune and truly depigmented without typical surface scale, while tinea versicolor is a superficial fungal disorder that often causes hypo- or hyperpigmented finely scaly patches. The presence of fine scale is an important clue against classic vitiligo.

How Is Vitiligo Different From Post-Inflammatory Hypopigmentation?

Post-inflammatory hypopigmentation follows prior inflammation or injury and usually reflects reduced pigment rather than the characteristic complete melanocyte-loss depigmentation of vitiligo. A preceding eczema, rash, burn or trauma history is often helpful here.

When Is a Skin Biopsy Needed?

Skin biopsy is only occasionally needed when the diagnosis remains uncertain or an atypical inflammatory disorder must be excluded. Routine biopsy is not necessary for most classic vitiligo presentations.

White-patch diagnostic path Illustrated diagnostic pathway for distinguishing vitiligo from other white or light patches using scale, texture, true depigmentation, Wood’s lamp findings and selective biopsy when uncertainty remains. White-Patch Diagnostic Path Goal: separate true depigmentation from partial pigment loss or scaly mimics. WHITE OR LIGHT PATCH start with appearance + distribution SCALE / TEXTURE? fine scale suggests fungal or inflammatory mimics, not classic vitiligo TRUE DEPIGMENTATION? sharply white, smooth, well-defined vs partial hypopigmentation WOOD’S LAMP helps confirm bright depigmentation and define subtle margins VITILIGO PLAUSIBLE classify segmental vs nonsegmental review autoimmune context selectively MIMIC OR UNCERTAINTY? consider pityriasis alba, tinea versicolor, post-inflammatory hypopigmentation biopsy only when atypical or still unclear skinkeeps.com
Figure 3. Vitiligo is usually a clinical diagnosis. Wood’s lamp examination helps confirm true depigmentation, while scale, incomplete pigment loss or a post-inflammatory history can point toward a different white-patch diagnosis.

How Is Vitiligo Treated and Which Options Can Restore Skin Color?

Vitiligo treatment is optional and individualized, with the main goals of stabilizing active disease, preventing new patches and encouraging repigmentation where the patient wants treatment.

Does Vitiligo Always Need Treatment?

No; treatment is optional and should reflect the patient’s goals, disease activity, affected sites, age and psychosocial impact. Some people choose observation or camouflage, while others prefer active repigmentation treatment.

What Are the Main Goals of Treatment?

Treatment aims to stabilize active vitiligo, limit new or enlarging patches and encourage repigmentation where possible. No current therapy guarantees a permanent cure, so success is measured by control and meaningful improvement rather than a promise of permanence.

How Are Topical Corticosteroids Used?

Prescription topical corticosteroids can suppress local immune inflammation and promote repigmentation in selected vitiligo patches. Site selection, potency and duration should be clinician-directed because prolonged potent use can thin the skin.

When Are Tacrolimus or Pimecrolimus Used?

Topical calcineurin inhibitors can be useful for selected areas such as the face and neck where prolonged topical corticosteroid exposure may be less desirable. They are used as prescription treatments rather than over-the-counter substitutes.

What Is Ruxolitinib Cream?

Topical ruxolitinib is a JAK-inhibitor treatment approved in the United States for repigmentation of nonsegmental vitiligo in adults and children aged 12 years and older. It should not be framed as universal first-line therapy for every patient, subtype or body site.

How Does Phototherapy Help Vitiligo?

Dermatologist-supervised narrowband UVB phototherapy can stimulate repigmentation, particularly when larger areas are affected. Response varies by body site, with the face and neck generally responding better than the hands, fingertips and feet.

When Is Vitiligo Surgery Considered?

Surgical repigmentation techniques are mainly considered for selected stable vitiligo, particularly stable segmental or resistant localized disease. Surgery is not recommended for actively spreading vitiligo because activity status strongly affects outcome.

When Is Depigmentation Therapy Considered?

Depigmentation therapy is reserved for rare, very extensive vitiligo when a patient elects to remove remaining pigment after specialist counseling. Because the result is often long-lasting or near-permanent, it belongs low in the treatment hierarchy.

Vitiligo treatment decision path Illustrated treatment decision path matching vitiligo therapies to disease activity, subtype, extent and stability. Vitiligo Treatment Decision Path Treatment is optional and should follow activity, subtype, extent, body site and patient goals. START WITH THE GOAL stabilize active disease • encourage repigmentation • protect skin LOCALIZED / ACTIVE topical corticosteroid or calcineurin inhibitor used selectively site and duration matter SUITABLE NONSEGMENTAL topical ruxolitinib adults + children 12+ selected by clinician not universal first-line for all WIDESPREAD DISEASE narrowband UVB often combined with topicals face/neck respond better than hands/feet controlled phototherapy ≠ sunbathing STABLE SELECTED surgical repigmentation for stable segmental or resistant localized disease avoid in actively spreading disease Rare end-path: depigmentation therapy may be considered only in very extensive disease after specialist counseling. skinkeeps.com
Figure 4. Vitiligo treatment is individualized. The main priorities are stabilizing active disease, encouraging repigmentation where desired and protecting depigmented skin; surgery belongs mainly to selected stable disease.

Can Vitiligo Spread or Return, and How Should Depigmented Skin Be Protected?

Vitiligo can spread, stabilize, repigment and later recur, so long-term care includes monitoring disease activity, protecting depigmented skin from sunburn and reassessing rapidly changing or treatment-resistant disease.

Can Vitiligo Spread Over Time?

Yes; nonsegmental vitiligo can expand, become stable and later reactivate, while segmental disease more often progresses for a limited period before stabilizing. The course is variable rather than continuously progressive in every person.

Can White Vitiligo Patches Repigment?

Yes; repigmentation can occur spontaneously or after topical treatment, phototherapy or selected surgical therapy. New pigment often begins around hair follicles because follicular melanocyte reservoirs can contribute to repigmentation.

Can Vitiligo Return After Successful Treatment?

Yes; treatment can restore pigment without permanently eliminating the autoimmune tendency, so some successfully repigmented areas may later lose color again. This is why maintenance strategies or periodic reassessment can matter.

Why Is Sun Protection Important?

Depigmented skin has less melanin protection and burns more easily, making sunscreen, shade and protective clothing important parts of long-term care. Intentional tanning is not a substitute for treatment and often increases contrast with surrounding skin.

Can Vitiligo Be Prevented Completely?

No proven method reliably prevents vitiligo from developing or recurring. Supplements, diet programs, detox methods and home remedies should not be marketed as guaranteed prevention strategies.

When Should Rapidly Spreading Vitiligo Be Reassessed?

Dermatology reassessment is useful when new patches appear quickly, existing areas enlarge rapidly or treatment no longer controls active disease. Active progression can change which treatments are appropriate.

When Should Associated Autoimmune Symptoms Be Reviewed?

Symptoms suggesting thyroid or another autoimmune disorder warrant clinical assessment because vitiligo can coexist with systemic autoimmune disease. That review should be symptom-guided rather than based on broad self-ordered testing.

When Should Quality-of-Life Impact Become Part of Treatment Planning?

Treatment planning should account for emotional or social impact when vitiligo significantly affects confidence, wellbeing or daily life. Respectful care means acknowledging that treatment is optional while also taking psychosocial burden seriously when it exists.

What Should You Remember About Vitiligo?

Vitiligo is a chronic autoimmune depigmentation disorder caused by melanocyte loss, and successful management depends on identifying the subtype and activity, confirming true depigmentation, choosing treatment according to patient goals and protecting affected skin.

  • Vitiligo is an autoimmune disorder in which melanocytes are targeted and pigment is lost.
  • It causes true depigmentation rather than generic hypopigmentation.
  • Patches are usually flat, smooth and milky white or fully depigmented.
  • Vitiligo is not contagious, not fungal and not hygiene-related.
  • Common sites include the face, hands, feet and trauma-prone areas.
  • Hair within patches can turn white, producing leukotrichia or poliosis.
  • Nonsegmental vitiligo is often bilateral or relatively symmetrical and can relapse.
  • Segmental vitiligo is usually unilateral and often stabilizes earlier.
  • The Koebner phenomenon means new lesions can appear at injury or friction sites in susceptible active disease.
  • Genetics influence susceptibility, but simple inheritance is not the rule and family history is not required.
  • Autoimmune thyroid disease is an important association, and other autoimmune disorders can coexist.
  • Sunburn risk is increased because depigmented skin has less melanin protection.
  • Diagnosis is usually clinical, and Wood’s lamp examination can help confirm true depigmentation.
  • Blood tests are selective rather than automatic for every person.
  • Vitiligo needs to be distinguished from hypopigmentation, pityriasis alba, tinea versicolor and post-inflammatory hypopigmentation.
  • Biopsy is uncommon and usually reserved for atypical or uncertain cases.
  • Treatment is optional, and the main goals are stabilization and repigmentation where desired.
  • Topical corticosteroids, calcineurin inhibitors, ruxolitinib, narrowband UVB and surgery each have specific roles.
  • Ruxolitinib has a specific FDA-approved use for nonsegmental vitiligo in adults and children aged 12 years and older.
  • Surgery belongs mainly to selected stable disease, not actively spreading vitiligo.
  • Vitiligo can spread, repigment and recur over time.
  • No proven method completely prevents vitiligo or guarantees a permanent cure.
  • Sun protection, monitoring and timely reassessment remain important long-term parts of care.
  • Psychosocial impact should be taken seriously and included in treatment planning when relevant.

Frequently Asked Questions About Vitiligo

The main vitiligo questions concern autoimmunity, subtype differences, progression, durability of repigmentation and contagiousness.

Is Vitiligo an Autoimmune Disease?

Yes; vitiligo is an autoimmune disorder in which immune-mediated damage causes loss of melanocytes and skin pigment.

What Is the Difference Between Segmental and Nonsegmental Vitiligo?

Nonsegmental vitiligo is usually bilateral or symmetrical and can have a relapsing course, while segmental vitiligo is usually unilateral and tends to stabilize after a more limited period of progression.

Can Vitiligo Spread to Other Parts of the Body?

Yes; particularly in nonsegmental disease, new patches can appear and existing patches can enlarge, although the course can alternate between active and stable periods.

Can Treatment Permanently Restore Skin Color?

Treatment can produce meaningful repigmentation, but no therapy guarantees permanent restoration because pigment can sometimes be lost again.

Is Vitiligo Contagious?

No; vitiligo is an autoimmune pigment disorder and cannot spread from one person to another through touch or close contact.

Sources & Evidence

NIAMS — Vitiligo: autoimmune basis, melanocyte destruction, milky-white patches, hair whitening, non-contagious nature, sun sensitivity and overall condition overview.

DermNet — Vitiligo: clinical patterns, nonsegmental and segmental classification, leukotrichia, Koebner phenomenon, autoimmune associations and differential diagnosis concepts.

American Academy of Dermatology — Vitiligo: Diagnosis and treatment: clinical diagnosis, Wood’s lamp examination, selective blood tests, treatment choices, body-site response differences and surgery being unsuitable for active disease.

American Academy of Dermatology — Vitiligo self-care: sun protection, avoiding tanning and skin injury, and supportive self-care principles.

FDA — Ruxolitinib approval for vitiligo: approval details for topical ruxolitinib in nonsegmental vitiligo for adults and children aged 12 years and older.

Beautiful Newsletter Form

Subscribe to the Newsletter

We send out research-backed guides every two weeks. Unsubscribe at any time.

Related ARTICLES